MedPath

深圳市贝美药业有限公司

Ownership
-
Established
2004-03-30
Employees
-
Market Cap
-
Website
http://www.beimeiyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Desloratadine Oral Solution

Product Name
地氯雷他定口服溶液
Approval Number
国药准字H20249820
Approval Date
Dec 25, 2024
NMPA

Procaterol Hydrochloride Inhalation Solution

Product Name
盐酸丙卡特罗吸入溶液
Approval Number
国药准字H20244886
Approval Date
Nov 25, 2024
NMPA

Procaterol Hydrochloride Oral Solution

Product Name
盐酸丙卡特罗口服溶液
Approval Number
国药准字H20244988
Approval Date
Sep 26, 2024
NMPA

Procaterol Hydrochloride Inhalation Solution

Product Name
盐酸丙卡特罗吸入溶液
Approval Number
国药准字H20244885
Approval Date
Sep 10, 2024
NMPA

Atomoxetine Hydrochloride Oral Solution

Product Name
盐酸托莫西汀口服溶液
Approval Number
国药准字H20233943
Approval Date
Jul 25, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.